close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

JNJ

228.31

-0.64%↓

UNH

370.71

+0.2%↑

TMO

470.73

-1.19%↓

ISRG

459.72

+1.12%↑

ABT

89.85

-0.84%↓

JNJ

228.31

-0.64%↓

UNH

370.71

+0.2%↑

TMO

470.73

-1.19%↓

ISRG

459.72

+1.12%↑

ABT

89.85

-0.84%↓

JNJ

228.31

-0.64%↓

UNH

370.71

+0.2%↑

TMO

470.73

-1.19%↓

ISRG

459.72

+1.12%↑

ABT

89.85

-0.84%↓

JNJ

228.31

-0.64%↓

UNH

370.71

+0.2%↑

TMO

470.73

-1.19%↓

ISRG

459.72

+1.12%↑

ABT

89.85

-0.84%↓

JNJ

228.31

-0.64%↓

UNH

370.71

+0.2%↑

TMO

470.73

-1.19%↓

ISRG

459.72

+1.12%↑

ABT

89.85

-0.84%↓

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Avatud

87.04 3.01

Tugev "osta" hinnang

Hinna uuendus 1. mai 2026, 15:38 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

83.98

Max

87.3

Põhinäitajad

By Trading Economics

Sissetulek

-557K

-36M

Müük

10M

22M

Aktsiakasum

-1.29

Kasumimarginaal

-165.447

Töötajad

63

EBITDA

10M

-19M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+66.32% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. mai 2026

Turustatistika

By TradingEconomics

Turukapital

946M

2.9B

Eelmine avamishind

84.03

Eelmine sulgemishind

87.04

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

30. apr 2026, 23:08 UTC

Tulu

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

DJ

Loe

30. apr 2026, 23:07 UTC

Tulu

Australia's Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

DJ

Loe

30. apr 2026, 22:20 UTC

Tulu

Australia's ANZ Raises 1st Half Profit 9%, Warns of Coming Iran Impacts

DJ

Loe

30. apr 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

DJ

Loe

30. apr 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

30. apr 2026, 23:47 UTC

Market Talk

Coles's Earnings Views Likely to Edge Down Despite Positives -- Market Talk

DJ

Loe

30. apr 2026, 23:27 UTC

Market Talk

Liontown Lithium Recovery Expected to Improve -- Market Talk

DJ

Loe

30. apr 2026, 23:22 UTC

Tulu

Apple's Incoming CEO John Ternus Makes Appearance as Company Bests Expectations -- Update

DJ

Loe

30. apr 2026, 23:20 UTC

Market Talk

Wildcat Resources Stands Out Among Lithium Developers -- Market Talk

DJ

Loe

30. apr 2026, 22:52 UTC

Tulu

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

DJ

Loe

30. apr 2026, 22:33 UTC

Tulu

Zhejiang Expressway: Impairment Loss Weighed on Net >0576.HK

DJ

Loe

30. apr 2026, 22:32 UTC

Tulu

Zhejiang Expressway 1Q Net CNY1.31B Vs. Net CNY1.48B >0576.HK

DJ

Loe

30. apr 2026, 22:32 UTC

Tulu

Zhejiang Expressway 1Q Rev CNY5.32B Vs. CNY4.36B >0576.HK

DJ

Loe

30. apr 2026, 22:24 UTC

Omandamised, ülevõtmised, äriostud

Mineral Resources: Also Reflects Time Needed to Implement Corporate Restructure For JV

DJ

Loe

30. apr 2026, 22:23 UTC

Omandamised, ülevõtmised, äriostud

Mineral Resources: Revised Timetable Reflects Time Needed to Get Regulatory Approvals

DJ

Loe

30. apr 2026, 22:23 UTC

Omandamised, ülevõtmised, äriostud

Mineral Resources: Now Expects Deal to Complete in 1H FY2027

DJ

Loe

30. apr 2026, 22:23 UTC

Omandamised, ülevõtmised, äriostud

Mineral Resources: Executes Key Formal Agreements With Posco on Stake Sale

DJ

Loe

30. apr 2026, 22:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

30. apr 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

30. apr 2026, 22:11 UTC

Market Talk

Apple Says Demand for Lower-Cost Laptop is Off the Charts -- Market Talk

DJ

Loe

30. apr 2026, 22:05 UTC

Tulu

Australia's ANZ Raises 1H Profit 9%, Warns of Coming Iran Impacts

DJ

Loe

30. apr 2026, 21:57 UTC

Tulu

ANZ CEO: Increase in Collective Provisions Reflects Risk>ANZ.AU

DJ

Loe

30. apr 2026, 21:56 UTC

Tulu

ANZ CEO: Minimal Impact on ANZ's Credit, Capital, Liquidity>ANZ.AU

DJ

Loe

30. apr 2026, 21:56 UTC

Tulu

ANZ CEO: No Material Increase in New Cases of Household Hardship>ANZ.AU

DJ

Loe

30. apr 2026, 21:55 UTC

Tulu

ANZ CEO: Households Entered Crisis With Generally Strong Balance Sheets>ANZ.AU

DJ

Loe

30. apr 2026, 21:54 UTC

Tulu

ANZ CEO: No Material Change in Overall Corporate Borrowing Behavior >ANZ.AU

DJ

Loe

30. apr 2026, 21:54 UTC

Tulu

ANZ CEO: Corporate Customers Have Been Building Capital, Liquidity Against Shocks>ANZ.AU

DJ

Loe

30. apr 2026, 21:53 UTC

Tulu

ANZ CEO: Much of Iran Conflict's Potential Impact Remains Ahead>ANZ.AU

DJ

Loe

30. apr 2026, 21:49 UTC

Tulu

ANZ Group 1H Total Operating Income A$11.20B Vs. A$10.995B>ANZ.AU

DJ

Loe

30. apr 2026, 21:49 UTC

Tulu

ANZ Group 1H Customer Deposits A$770.7B Vs. A$756.6B>ANZ.AU

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

66.32% tõus

12 kuu keskmine prognoos

Keskmine 138.38 USD  66.32%

Kõrge 185 USD

Madal 95 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

7

Osta

1

Hoia

0

Müü

Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

JNJ

Johnson and Johnson

228.31

↓-0.64%

UNH

UnitedHealth Group Inc

370.71

↑ +0.2%

TMO

Thermo Fisher Scientific Inc

470.73

↓-1.19%

ISRG

Intuitive Surgical Inc

459.72

↑ +1.12%

ABT

Abbott Laboratories

89.85

↓-0.84%
help-icon Live chat